Laura E. Niklason - Aug 29, 2024 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
President, CEO and Director, Director
Signature
/s/ Laura E. Niklason by Dale A. Sander as Attorney-in-Fact
Stock symbol
HUMA
Transactions as of
Aug 29, 2024
Transactions value $
$7,998
Form type
4
Date filed
9/3/2024, 04:23 PM
Previous filing
Aug 29, 2024
Next filing
Sep 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Purchase $8K +1.22K +0.51% $6.55 242K Aug 29, 2024 Direct F1
holding HUMA Common Stock 1.15M Aug 29, 2024 By The Niklason Living Trust
holding HUMA Common Stock 510K Aug 29, 2024 By spouse
holding HUMA Common Stock 3.68M Aug 29, 2024 By Ayabudge LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This purchase is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, against a portion of the sale by Ayabudge LLC, an entity controlled by the Reporting Person's spouse, of 809,786 shares of the Issuer's common stock on May 31, 2024. The Reporting Person has paid the Issuer $3,391.05, representing the full amount of profit realized in connection with this purchase.